论文部分内容阅读
目的:分析与探讨扁桃体癌不同的治疗方案与疗效的关系。方法:1987年10月～1995年12月间收治了95例扁桃体癌,均经病理证实。8例采用联合根治术加化疗,9例为联合根治术加术后放疗,62例单纯根治性放疗,16例用根治性放疗加化疗。结果:本组1年、3年和5年生存率分别为86.32％,62.93％和56.26％。8例手术加化疗的患者仅1例存活5年,四种治疗情况对其5年生存率和局部控制率的影响具有显著性差异(P<0.05)。结论:首选根治性放射治疗对扁桃体癌疗效确切;有计划地进行手术与放疗及化疗与放疗进行综合治疗具有临床研究价值。
Objective: To analyze and explore the relationship between different treatment options and curative effect of tonsil cancer. Methods: From October 1987 to December 1995, 95 cases of tonsillar carcinoma were treated, all confirmed by pathology. Eight patients received combined radical mastectomy plus chemotherapy, nine patients received combined radical mastectomy plus postoperative radiotherapy, 62 patients received radical radiotherapy alone, and 16 patients received radical radiotherapy plus chemotherapy. Results: The 1-year, 3-year and 5-year survival rates were 86.32%, 62.93% and 56.26% respectively. Only one patient survived for 5 years in 8 cases treated with chemotherapy plus chemotherapy. There was a significant difference in the 5-year survival rate and local control rate between the four treatment groups (P <0.05). Conclusions: The first choice of radical radiotherapy for tonsil cancer is effective; planned surgery and radiotherapy and chemotherapy and radiotherapy for the comprehensive treatment of clinical research value.